Related Experiment Video
Updated: Jun 2, 2026

10:31
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Profiling the proteome in renal transplantation
Tara K Sigdel1, Sangho Lee, Minnie M Sarwal
1Department of Pediatrics - Nephrology, Stanford University Medical School, Stanford University, Stanford, CA, USA.
Proteomics. Clinical Applications
|April 27, 2011
Summary
Identifying reliable protein biomarkers is key to improving transplanted organ survival. This review discusses proteomic strategies and challenges in renal transplantation to guide future biomarker discovery.
Area of Science:
- Biomarker Discovery
- Proteomics
- Renal Transplantation
Background:
- Improved monitoring of transplanted organs is crucial for patient and allograft survival.
- Surrogate biomarker molecules can indicate the health status of transplanted organs.
- High-throughput omic methods, like proteomics, aid in analyzing genes and proteins.
Purpose of the Study:
- To describe current proteomic-based biomarker discovery strategies in renal transplantation.
- To discuss challenges hindering successful biomarker discovery and clinical implementation.
- To propose improved strategies for effective biomarker discovery in kidney transplantation.
Main Methods:
- Review of current proteomic techniques for biomarker identification.
- Analysis of challenges in sample processing, transportation, and standardization.
- Discussion of the need for collaborative efforts to increase clinical study sample sizes.
Main Results:
- Proteomics has shown achievements in profiling proteins and identifying potential biomarkers for renal transplantation.
- Significant challenges remain, including lack of standardized protocols and difficulties in sample handling.
- Limited collaborative efforts hinder the achievement of adequate sample sizes for robust clinical studies.
Conclusions:
- Proteomic-based biomarker discovery holds promise for enhancing renal transplant outcomes.
- Addressing issues like standardization, sample logistics, and collaboration is essential for clinical translation.
- Developing better strategies is necessary to overcome current hurdles and achieve successful biomarker implementation.
